|

Recommendations for Contraceptive Use |
|
|
|
|
Copper-Bearing Intrauterine Devices (IUDs)
|
Classification of Selected
Procedures for Intrauterine Devices (IUDs)
Procedure |
Class |
Rationale |
| Pelvic examination (speculum and
bimanual) |
A |
- Bimanual and speculum exams are mandatory before IUD use,
to rule out contraindications: pregnancy, pelvic inflammatory disease (PID) and
endocervical infection, and to determine uterine position in order to avoid perforation.
- If the woman is pregnant, presence of the IUD will lead to
spontaneous abortion (miscarriage) in about half of all pregnancies, and there is
significant risk of septic abortion1.
- If a purulent endocervical discharge is present, at the
time the IUD is inserted through the cervical canal, bacteria in the canal may be
introduced into the sterile uterine cavity and lead to PID1. The woman and her
partner(s) must be treated before considering IUD insertion.
|
| Blood pressure |
C |
- IUD use does not affect blood pressure2.
- Screening for high blood pressure is part of optimal
preventive health care.
|
| Breast examination |
C |
- For all women of reproductive age or beyond, a breast exam
is recommended for optimal health care.
- IUD use does not cause (nor increase the risk of)
breast cancer.
|
| STD screening by history |
A |
- Assessment of STD risk by personal history and
socio-demographic risk factors is an important method of identifying women at risk of PID.
- Assessment of STD risk permits empiric therapy of client
and presumptive treatment of partner.
|
| Sexually transmitted disease
(STD) screening by lab tests (for asymptomatic persons) |
B |
- Assessment of STD risk by personal history and
socio-demographic risk factors may be the most practical method of identifying women at
risk for PID. The speculum and bimanual exam may also detect some STDs. Although STD lab
tests may not be practical or affordable in many settings, in some cases it may be
reasonable to supplement screening by history and physical exam with certain lab tests,
especially where the client or the provider is concerned that the client may be of risk
for STDs (clients with current signs or symptoms of STDs are not eligible for IUDs). When
feasible, negative test results provide reassurance to corroborate the woman's history. It
is important to try to avoid the imposition of additional visits in weighing the value of
such tests.
- For those clients with a personal history or with
socio-demographic risk factors which suggest high risk, the client who still makes an
informed choice of an IUD must understand she may have an STD without any signs or
symptoms.
|
| Cervical cancer screening |
C |
- Cervical cancer screening is indicated for women at risk of
cervical carcinoma, and is recommended for optimal preventive health care for women of
reproductive age or beyond (particularly women at risk of STDs).
NOTE: Cervical cancer screening is advised for
optimal preventive care for all women at risk of cervical cancer (e.g., smokers, women
with partners having multiple partners, women with young age at first intercourse, etc.).
All women at risk should ideally have access to a practical method of cervical cancer
screening, treatment and follow up.
- IUD insertions and continued IUD use have no known relation
to the risk of acquiring cervical carcinoma 3.
|
| Routine, mandatory lab tests
(e.g., cholesterol, glucose, liver function tests) |
D |
Irrelevant to the use of
copper-releasing IUDs for contraception. |
- efficacy
- common side effects
- correct use of method
- signs and symptoms for which to return to the clinic
- STD protection (when/as appropriate)
|
A |
- Accurate client education is essential for maximum quality
of family planning services.
- Appropriate counseling about common contraceptive side
effects at the time of method selection can lead to improved client satisfaction and
contraceptive continuation4.
|
Specific counseling points
related to IUDs:
- Counseling concerning change in menses, including increased
bleeding with copper- bearing IUDs.
|
A |
- As in pre-method choice counseling, the women should be
informed that menses are normally heavier with the IUD and intermenstrual bleeding may
occur, particularly post insertion. Inert IUDs approximately double normal menstrual blood
loss and copper IUDs may increase it by 50%, which may be clinically significant for women
who are already anemic. The more progestin an IUD releases, the more effectively it
decreases menstrual blood loss 5.
|
|
|
|
- Women at risk should be counseled on high risk behavior for
contracting STDs and potential complications from IUD use. Women should be instructed to
return to the clinic for: abdominal pain, pain with intercourse, abnormal vaginal
discharge or pelvic pain, especially with fever, or if the IUD string is missing or
appears to be longer or shorter or if the client is not pleased with the method.
|
- Counseling about condom use for women who, under certain
circumstances, might become at high risk for STDs.
|
|
- When condoms are used as a back-up method, counseling
should be given to increase correct use and compliance.
- Condoms offer the greatest potential for preventing STD
spread among persons at risk for STDs.
|
| NOTE: Women who are
currently at high risk for STDs, in general should not receive IUDs. |
|
- Counseling sessions providing skill training may increase
the rate of condom use.
|
KEY:
Class A = essential and mandatory or otherwise
important in all circumstances, for safe and effective use of the contraceptive method
Class B = medically/epidemiologically rational in
some circumstances to optimize the safe and effective use of the contraceptive method, but
may not be appropriate for all clients in all settings
Class C = may be appropriate for good preventive
health care, but not materially related to safe and effective use of the contraceptive
method
Class D = not materially related to either good
routine preventive health care or to the safe and effective use of the contraceptive
method
Citations:
Mishell DR, Jr. Contraception, sterilization,
and pregnancy termination, in Herbst AL, Mishell DR Jr., Stenchever MA, Droegmueller W
(eds). Comprehensive Gynecology, 2nd edition. St. Louis, Mosby Year Book, 1992, pp
295-362.
WHO Special Programme of Research, Development
and Research Training in Human Reproduction. The WHO multicentre trial of the vasopressor
effects of combined oral contraceptives: 1. Comparisons with IUD. Contraception
1989;40(2):129-145.
Lassise DL, Savitz DA, Hamman RF, Barón AE,
Brinton LA, Levines RS. Invasive cervical cancer and intrauterine device use. International
Journal of Epidemiology 1991;20(4):865-870.
Cotten N, Standback J, Maidouka H,
Taylor-Thomas JT, Turk T. Early discontinuation of contraceptive use in Niger and The
Gambia. International Family Planning Perspectives 1992;18(4):145-149.
Andrade A, Pizarro E. Quantitative studies on
menstrual blood loss in IUD users. Contraception 1987;36(1):129-144. |